Congenital Central Hypoventilation Syndrome a Neurocristopathy with Disordered Respiratory Control and Autonomic Regulation

Total Page:16

File Type:pdf, Size:1020Kb

Congenital Central Hypoventilation Syndrome a Neurocristopathy with Disordered Respiratory Control and Autonomic Regulation Congenital Central Hypoventilation Syndrome A Neurocristopathy with Disordered Respiratory Control and Autonomic Regulation Casey M. Rand, BSa, Michael S. Carroll, PhDa,b, Debra E. Weese-Mayer, MDa,b,* KEYWORDS PHOX2B Autonomic Respiratory CCHS Hirschsprung Neuroblastoma KEY POINTS Congenital central hypoventilation syndrome (CCHS) is a rare neurocristopathy with disordered respiratory control and autonomic nervous system regulation. CCHS is caused by mutations in the PHOX2B gene, and the PHOX2B genotype/mutation antici- pates the CCHS phenotype, including the severity of hypoventilation, risk of sinus pauses, and risk of associated disorders including Hirschsprung disease and neural crest tumors. It is important to maintain a high index of suspicion in cases of unexplained alveolar hypoventilation, delayed recovery of spontaneous breathing after sedation or anesthesia, or in the event of severe respiratory infection, and unexplained seizures or neurocognitive delay. This will improve identifica- tion and diagnosis of milder CCHS cases and later onset/presentation cases, allowing for success- ful intervention. Early intervention and conservative management are key to long-term outcome and neurocognitive development. Research is underway to better understand the underlying mechanisms and identify targets for treatment advances and drug interventions. INTRODUCTION with autonomic nervous system dysregulation (ANSD), and a result of maldevelopment of neural Congenital central hypoventilation syndrome crest-derived cells (neurocristopathy). The first re- (CCHS) is a rare disorder of respiratory control ported description of CCHS was in 1970 by This work was supported in part by the Chicago Community Trust Foundation PHOX2B Patent Fund and Res- piratory & Autonomic Disorders of Infancy, Childhood, & Adulthood–Foundation for Research & Education (RADICA-FRE). a Center for Autonomic Medicine in Pediatrics (CAMP), Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, 225 East Chicago Avenue, Chicago, IL 60611-2605, USA; b Department of Pediatrics, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611, USA * Corresponding author. E-mail addresses: [email protected]; [email protected] Clin Chest Med 35 (2014) 535–545 http://dx.doi.org/10.1016/j.ccm.2014.06.010 0272-5231/14/$ – see front matter Ó 2014 Elsevier Inc. All rights reserved. chestmed.theclinics.com 536 Rand et al Robert Mellins and colleagues.1 Despite a multi- hypoventilation) during sleep and, in more severely tude of case reports, large series were not pub- affected individuals, during wakefulness and lished until 1992.2 As of early 2014, laboratories sleep. These breathing complications occur des- from the United States, France, Italy, Japan, Ger- pite the lungs and airways being anatomically many, China, The Netherlands, and Australia have and physiologically normal. Conditions associated now collectively diagnosed approximately 1200 with CCHS reflecting anatomic ANSD include cases with PHOX2B mutation-confirmed CCHS. Hirschsprung disease (HSCR) and tumors of neu- However, the birth prevalence of CCHS is un- ral crest origin, in addition to a spectrum of symp- known, because demographically diverse, large, toms compatible with physiologic ANSD. CCHS is population-based studies have not been reported. a life-long disease. Because the milder cases of CCHS and later- onset (LO) CCHS may go unrecognized or mis- PHOX2B Gene Mutations diagnosed, it is difficult to estimate the true frequency of CCHS in the general population at Individuals with CCHS have a mutation in this time. PHOX2B, a gene that plays an important role in CCHS is characteristically diagnosed in the the development of the ANS. The normal PHOX2B newborn period. However, individuals can also gene has 20 repeats of the amino acid alanine. be diagnosed in childhood3–6 or adulthood,5,7–13 Approximately 90% of individuals with CCHS are depending on the severity of symptoms and the in- heterozygous for a PHOX2B polyalanine repeat quisivity of the patient, family, and medical team. expansion mutation (PARM), with expansions to Impaired breathing regulation (respiratory control) 24 to 33 alanine repeats on the affected allele,14 is the hallmark of CCHS. Individuals with CCHS genotypes of 20/24 to 20/33 (normal genotype is typically present with shallow breathing (alveolar 20/20; Fig. 1). The remaining 9% to 10% of Fig. 1. PHOX2B gene with location of all CCHS-associated mutations identified to date. Nearly all polyalanine repeat expansion mutations (PARMs) are located within the second polyalanine expansion region of exon 3 (shown in red). Nearly all NPARMs identified thus far have been found at the extreme 30 end of exon 2 or in exon 3. (Adapted from Weese-Mayer DE, Rand CM, Berry-Kravis EM, et al. Congenital central hypoventilation syn- drome from past to future: model for translational and transitional autonomic medicine. Pediatr Pulmonol 2009;44:526; with permission.) CCHS: A Neurocristopathy 537 individuals with CCHS and LO-CCHS have a or exon deletions makes prediction of phenotype different type of alteration in the PHOX2B gene, difficult in these cases, but thus far disease seems referred to as non-PARM (NPARM). These muta- to be less severe in these cases. Typically, dys- tions include missense, nonsense, frameshift, function of PHOX2B during development is en- and stop codon mutations, mostly occurring in ough to cause manifestation of disease from the exon 2 and exon 3 of PHOX2B. Fewer than 1% neonatal period; however, the less severe muta- of individuals with CCHS/LO-CCHS or CCHS-like tions may be “unmasked” by challenges to the symptoms will have whole gene or exon deletions respiratory system, such as respiratory infection of PHOX2B,15 and are phenotypically variable. or exposure to sedation, which can lead to fully Among PARMS, the 20/25, 20/26, and 20/27 manifest disease symptoms. genotypes, and among NPARMs, a 38-bp dele- tion at the site of the polyalanine repeat, remain Genotype–Phenotype Correlations the most frequently identified mutations. CCHS- The symptoms and severity of CCHS vary from PHOX2B related mutations have not been one individual to another (Fig. 2).20 This variation found in thoroughly screened control populations. is becoming clearer as these patients are studied Although de novo germline mutations cause the by PHOX2B genotype/mutation, such that repeat majority of CCHS cases, an autosomal-dominant length and PARM versus NPARM are related to inheritance pattern exists for CCHS. This includes disease severity. A rapidly expanding understand- somatic mosaicism, identified in a subset (5%– ing of the risks specific to the particular PHOX2B 16–18 25%) of parents of CCHS probands, as well mutation is allowing physicians and parents to as inheritance from a fully affected parent (with anticipate risks for continuous ventilation, pauses CCHS). in the heart rhythm, HSCR, neural crest tumors, PHOX2B Mutations in result in altered develop- and potential factors that influence autonomic ment and regulation of the ANS, primarily by regulation in individuals with CCHS. abnormal development in progenitors of early em- bryonic cells that form the neural crest (hence the Ventilatory dependence term neurocristopathy19). Individuals with the In individuals with PARMs, the need for continuous NPARMs are typically more severely affected ventilatory dependence has a direct relationship than individuals with the PARMs, and individuals with the length of the alanine expansions.3,17,21 with a greater number of alanine repeats are typi- Specifically, individuals with the 20/25 genotype cally more severely affected than those with fewer rarely require 24-hour ventilatory support; individ- (especially among the most common PARMs). The uals with the 20/26 genotype have variable awake small number of identified cases with whole-gene needs, depending on the level of activity; and Fig. 2. Signs and symptoms of CCHS-related ANS dysregulation. (From Weese-Mayer DE, Patwari PP, Rand CM, et al. Congenital central hypoventilation syndrome (CCHS) and PHOX2B mutations. Primer on the autonomic ner- vous system. 3rd edition. Oxford: Elsevier; 2012; with permission.) 538 Rand et al individuals with genotypes from 20/27 to 20/33 paraspinal ganglia or the adrenal glands. Neural very often require continuous ventilatory support. crest tumors in individuals with the NPARMs are LO-CCHS cases with the 20/24 or 20/25 typically neuroblastomas, in contrast with the gan- genotype5,7,8 have the mildest hypoventilation, glioneuromas and ganglioneuroblastomas in indi- presenting primarily after exposure to respiratory viduals with the longest PARMs (20/30–20/33). depressants or severe respiratory infection, and However, in 1 case a child with the 20/33 geno- may often be managed with nocturnal ventilatory type presented with a neuroblastoma. support only. In contrast with the PARMs, most in- dividuals with NPARMs require continuous ventila- ANSD tory support (Fig. 3).21 An increased number of symptoms of ANSD has been reported in association with PHOX2B geno- Hirschsprung disease and tumors of neural type in individuals with CCHS.17 These symptoms crest origin can include heart rhythm abnormalities, such as Some individuals with CCHS have anatomic/ prolonged asystoles (>3 seconds) necessitating a structural malformations including HSCR and cardiac pacemaker,22 altered gut motility even in tumors of neural crest origin. Overall,
Recommended publications
  • Participant Guide
    Participant Guide Get Enough Sleep Session Focus Getting enough sleep can help you prevent or delay type 2 diabetes. This session we will talk about: z Why sleep matters z Some challenges of getting enough sleep and ways to cope with them You will also make a new action plan! Tips: ✓ Go to bed and get up at the same time each day. This helps your body get on a schedule. ✓ Follow a bedtime routine that helps you wind down. Participant Guide: Get Enough Sleep 2 Jenny’s Story Jenny is at risk for type 2 diabetes. Her doctor asks her if she gets at least 7 hours of sleep each night. Jenny laughs. “Are you serious?” she asks. “I’m lucky if I get 5 hours.” Jenny usually doesn’t have much trouble falling asleep. But she often has to use the bathroom in the early morning. This gets her thinking about all the things she needs to do the next day. Plus, her husband’s breathing is loud. Both of these things make it hard for Jenny to fall back to sleep. She often lies awake for hours. These days, Jenny drinks less water and avoids caffeine in the evening. She makes a list of things to do the next day. Then she sets it aside. Jenny rarely needs to get up to use the bathroom during the night. If she does, she breathes deeply to help her get back to sleep. She also runs a fan to cover up the sound of her husband’s breathing. Jenny is closer to getting 7 hours of sleep a night.
    [Show full text]
  • Approach to Cyanosis in a Neonate.Pdf
    PedsCases Podcast Scripts This podcast can be accessed at www.pedscases.com, Apple Podcasting, Spotify, or your favourite podcasting app. Approach to Cyanosis in a Neonate Developed by Michelle Fric and Dr. Georgeta Apostol for PedsCases.com. June 29, 2020 Introduction Hello, and welcome to this pedscases podcast on an approach to cyanosis in a neonate. My name is Michelle Fric and I am a fourth-year medical student at the University of Alberta. This podcast was made in collaboration with Dr. Georgeta Apostol, a general pediatrician at the Royal Alexandra Hospital Pediatrics Clinic in Edmonton, Alberta. Cyanosis refers to a bluish discoloration of the skin or mucous membranes and is a common finding in newborns. It is a clinical manifestation of the desaturation of arterial or capillary blood and may indicate serious hemodynamic instability. It is important to have an approach to cyanosis, as it can be your only sign of a life-threatening illness. The goal of this podcast is to develop this approach to a cyanotic newborn with a focus on these can’t miss diagnoses. After listening to this podcast, the learner should be able to: 1. Define cyanosis 2. Assess and recognize a cyanotic infant 3. Develop a differential diagnosis 4. Identify immediate investigations and management for a cyanotic infant Background Cyanosis can be further broken down into peripheral and central cyanosis. It is important to distinguish these as it can help you to formulate a differential diagnosis and identify cases that are life-threatening. Peripheral cyanosis affects the distal extremities resulting in blue color of the hands and feet, while the rest of the body remains pinkish and well perfused.
    [Show full text]
  • Sleep Apnea Sleep Apnea
    Health and Safety Guidelines 1 Sleep Apnea Sleep Apnea Normally while sleeping, air is moved at a regular rhythm through the throat and in and out the lungs. When someone has sleep apnea, air movement becomes decreased or stops altogether. Sleep apnea can affect long term health. Types of sleep apnea: 1. Obstructive sleep apnea (narrowing or closure of the throat during sleep) which is seen most commonly, and, 2. Central sleep apnea (the brain is causing a change in breathing control and rhythm) Obstructive sleep apnea (OSA) About 25% of all adults are at risk for sleep apnea of some degree. Men are more commonly affected than women. Other risk factors include: 1. Middle and older age 2. Being overweight 3. Having a small mouth and throat Down syndrome Because of soft tissue and skeletal alterations that lead to upper airway obstruction, people with Down syndrome have an increased risk of obstructive sleep apnea. Statistics show that obstructive sleep apnea occurs in at least 30 to 75% of people with Down syndrome, including those who are not obese. In over half of person’s with Down syndrome whose parents reported no sleep problems, sleep studies showed abnormal results. Sleep apnea causing lowered oxygen levels often contributes to mental impairment. How does obstructive sleep apnea occur? The throat is surrounded by muscles that are active controlling the airway during talking, swallowing and breathing. During sleep, these muscles are much less active. They can fall back into the throat, causing narrowing. In most people this doesn’t affect breathing. However in some the narrowing can cause snoring.
    [Show full text]
  • Towards a Passive BCI to Induce Lucid Dream Morgane Hamon, Emma Chabani, Philippe Giraudeau
    Towards a Passive BCI to Induce Lucid Dream Morgane Hamon, Emma Chabani, Philippe Giraudeau To cite this version: Morgane Hamon, Emma Chabani, Philippe Giraudeau. Towards a Passive BCI to Induce Lucid Dream. Journée Jeunes Chercheurs en Interfaces Cerveau-Ordinateur et Neurofeedback 2019 (JJC- ICON ’19), Mar 2019, Villeneuve d’Ascq, France. hal-02108903 HAL Id: hal-02108903 https://hal.archives-ouvertes.fr/hal-02108903 Submitted on 29 Apr 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. TOWARDS A PASSIVE BCI TO INDUCE LUCID DREAM JJC-ICON ’19 Morgane Hamon Emma Chabani Philippe Giraudeau Ullo Institut du Cerveau et de la Moelle épinière Inria La Rochelle, France Paris, France Bordeaux, France [email protected] [email protected] [email protected] April 29, 2019 ABSTRACT Lucid dreaming (LD) is a phenomenon during which the person is aware that he/she dreaming and is able to control the dream content. Studies have shown that only 20% of people can experience lucid dreams on a regular basis. However, LD frequency can be increased through induction techniques. External stimulation technique relies on the ability to integrate external information into the dream content.
    [Show full text]
  • Chest Pain and the Hyperventilation Syndrome - Some Aetiological Considerations
    Postgrad Med J: first published as 10.1136/pgmj.61.721.957 on 1 November 1985. Downloaded from Postgraduate Medical Journal (1985) 61, 957-961 Mechanism of disease: Update Chest pain and the hyperventilation syndrome - some aetiological considerations Leisa J. Freeman and P.G.F. Nixon Cardiac Department, Charing Cross Hospital (Fulham), Fulham Palace Road, Hammersmith, London W6 8RF, UK. Chest pain is reported in 50-100% ofpatients with the coronary arteriograms. Hyperventilation and hyperventilation syndrome (Lewis, 1953; Yu et al., ischaemic heart disease clearly were not mutually 1959). The association was first recognized by Da exclusive. This is a vital point. It is time for clinicians to Costa (1871) '. .. the affected soldier, got out of accept that dynamic factors associated with hyperven- breath, could not keep up with his comrades, was tilation are commonplace in the clinical syndromes of annoyed by dizzyness and palpitation and with pain in angina pectoris and coronary insufficiency. The his chest ... chest pain was an almost constant production of chest pain in these cases may be better symptom . .. and often it was the first sign of the understood if the direct consequences ofhyperventila- disorder noticed by the patient'. The association of tion on circulatory and myocardial dynamics are hyperventilation and chest pain with extreme effort considered. and disorders of the heart and circulation was ackn- The mechanical work of hyperventilation increases owledged in the names subsequently ascribed to it, the cardiac output by a small amount (up to 1.3 1/min) such as vasomotor ataxia (Colbeck, 1903); soldier's irrespective of the effect of the blood carbon dioxide heart (Mackenzie, 1916 and effort syndrome (Lewis, level and can be accounted for by the increased oxygen copyright.
    [Show full text]
  • Obstructive Sleep Apnea in Adults? NORMAL AIRWAY OBSTRUCTED AIRWAY
    American Thoracic Society PATIENT EDUCATION | INFORMATION SERIES What Is Obstructive Sleep Apnea in Adults? NORMAL AIRWAY OBSTRUCTED AIRWAY Obstructive sleep apnea (OSA) is a common problem that affects a person’s breathing during sleep. A person with OSA has times during sleep in which air cannot flow normally into the lungs. The block in CPAP DEVICE airflow (obstruction) is usually caused by the collapse of the soft tissues in the back of the throat (upper airway) and tongue during sleep. Apnea means not breathing. In OSA, you may stop ■■ Gasping breathing for short periods of time. Even when you are or choking trying to breathe, there may be little or no airflow into sounds. the lungs. These pauses in airflow (obstructive apneas) ■■ Breathing pauses observed by someone watching can occur off and on during sleep, and cause you to you sleep. wake up from a sound sleep. Frequent apneas can cause ■■ Sudden or jerky body movements. many problems. With time, if not treated, serious health ■■ Restless tossing and turning. problems may develop. ■■ Frequent awakenings from sleep. OSA is more common in men, women after menopause CLIP AND COPY AND CLIP Common symptoms you may have while awake: and people who are over the age of 65. OSA can also ■■ Wake up feeling like you have not had enough sleep, occur in children. Also see ATS Patient Information Series even after sleeping many hours. fact sheet on OSA in Children. People who are at higher ■■ Morning headache. risk of developing sleep apnea include those with: ■■ Dry or sore throat in the morning from breathing ■■ enlarged tonsils and/or adenoids through your mouth during sleep.
    [Show full text]
  • Sleep Self-Care
    University of California, Berkeley 2222 Bancroft Way Berkeley, CA 94720 SLEEP SELF-CARE All of us have trouble sleeping from time to time. This is perfectly normal. Sleep problems (also known as insomnia) are often triggered by sudden life changes that lead to increased stress. For instance, following the death of a loved one, a car accident or a promotion to a new job, many people experience difficulties getting a good night’s sleep. This normal response to stress usually lasts for a short time, rarely longer than a week or two. However, some people have chronic problems sleeping which do not seem to go away. If you are one of these people, or you are having temporary insomnia, this Self-Care Guide should help. It will give you some general information about sleep, as well as provide a number of helpful suggestions to aid those with sleep problems. Read it carefully, as many common sleep problems are caused by one’s own habits, and by adopting some of the following sleep-promoting behaviors, most people can get a good night’s rest without the aid of drugs. Taking sleeping pills is not the answer! For people whose only complaint is I can’t sleep well or I can’t get to sleep easily, taking sleeping pills may do more harm than good. Most authorities recommend against the regular use of sedative drugs (like Valium, Dalmane, Librium and barbiturates) for the following reasons: ! Sedatives change nervous system activities during sleep; for example, they may reduce the normal periods of dreaming.
    [Show full text]
  • Central Hypoventilation with PHOX2B Expansion Mutation Presenting in Adulthood S Barratt, a H Kendrick, F Buchanan, a T Whittle
    919 CASE REPORT Thorax: first published as 10.1136/thx.2006.068908 on 1 October 2007. Downloaded from Central hypoventilation with PHOX2B expansion mutation presenting in adulthood S Barratt, A H Kendrick, F Buchanan, A T Whittle ................................................................................................................................... Thorax 2007;62:919–920. doi: 10.1136/thx.2006.068908 suggested cardiac enlargement and an ECG showed right heart Congenital central hypoventilation syndrome most commonly strain. Oxygen saturation by pulse oximetry (SpO2) on air was presents in neonates with sleep related hypoventilation; late 80% and arterial blood gas analysis on 24% fractional inspired onset cases have occurred up to the age of 10 years. It is oxygen showed hypercapnic respiratory failure (pH 7.21, associated with mutations in the PHOX2B gene, encoding a oxygen tension 8.6 kPa, carbon dioxide tension 10.3 kPa). He transcription factor involved in autonomic nervous system was polycythaemic with haematocrit 64%. He was treated with development. The case history is described of an adult who antibiotics, diuretics, controlled oxygen therapy and face mask presented with chronic respiratory failure due to PHOX2B non-invasive positive pressure ventilation (NIV). mutation-associated central hypoventilation and an impaired From day 2 his daytime oxygenation was satisfactory on low response to hypercapnia. flow oxygen without ventilatory support; he remained on nocturnal NIV. Two attempts to record overnight oximetry without ventilatory support failed: his SpO2 fell below 50% due ongenital central hypoventilation syndrome (CCHS, to apnoea within 30 min of sleep onset and the nursing staff ‘‘Ondine’s Curse’’) classically presents in neonates with recommenced NIV on each occasion. Overnight oximetry on air Csleep-dependent hypoventilation.
    [Show full text]
  • Brain Computer Interface for Sleep Apnea Detection
    Special Issue - 2020 International Journal of Engineering Research & Technology (IJERT) ISSN: 2278-0181 NCAIT - 2020 Conference Proceedings Brain Computer Interface for Sleep Apnea Detection Poorvitha H R1, Aishwarya K Gowda2, Kavya K B2, Nayana R2 Vivekananda Institute of Technology Gudimavu, Kumbalagodu Post, Kengeri Hobli, Bengaluru – 560 074 Abstract - A brain-computer interface (BCI) is the varied phases of sleep and may be a crucial step in a interface method that someone to deliver instructions and shot to assist doctor within the designation and medical messages to a automated gadget, via way of means of care of connected sleep obstruction. using person mind activity. An electroencephalogram (EEG), mounted BCI became related with a synthetic gadget to command a home automation application. It provides an alternative to built-in interface and control. It is a digital surroundings shape that enters the body’s everyday prepared pathways, which might be neuromuscular output passage. Sleep apnea is personification of sickness which occurs during sleep, which impacts the human fitness via way of means of blockage in respiratory for positive period of time. The prognosis is critical that's viable via way of means of the perceiving of apnea episodes the use of electroencephalogram (EEG) reports. EEG is an adjustable decomposition for the identifying of apnea events using EEG signals. EEG plays an essential role in identifying the sleep apnea by recognizing and producing the brain neurons activities. The EEG sign dataset is filtered, the purified EEG sign is subjected for sub-band separation and 5 frequency bands inclusive of Gamma, Beta, Alpha, Theta, and Delta.
    [Show full text]
  • What%Is%Idiopathic%Hypersomnia?%
    What%is%Idiopathic%Hypersomnia?% Idiopathic*hypersomnia*is*sleeping*too*much*(hypersomnia)*without*an*obvious*cause.*It*is*different* from*narcolepsy,*because*idiopathic*hypersomnia*does*not*involve*suddenly*falling*asleep*or*losing* muscle*control*due*to*strong*emotions*(cataplexy).* Causes* The*usual*approach*is*to*consider*other*potential*causes*of*excessive*daytime*sleepiness.* Other*sleep*disorders*that*may*cause*daytime*sleepiness*include:* •Isolated*sleep*paralysis* •Narcolepsy* •Obstructive*sleep*apnea* •Restless*leg*syndrome* Other*causes*of*excessive*sleepiness*include:* •Atypical*depression* •Certain*medications* •Drug*and*alcohol*use* •Low*thyroid*function*(hypothyroidism)* •Previous*head*injury* Symptoms* Symptoms*often*develop*slowly*during*adolescence*or*young*adulthood.*They*include:* •Daytime*naps*that*do*not*relieve*drowsiness* •Difficulty*waking*from*a*long*sleep*KK*may*feel*confused*or*disoriented* •Increased*need*for*sleep*during*the*day*KK*even*while*at*work,*or*during*a*meal*or*conversation* •Increased*sleep*time*KK*up*to*14*K*18*hours*per*day* Other*symptoms*may*include:* •Anxiety* •Feeling*irritated* •Loss*of*appetite* •Low*energy* •Restlessness* •Slow*thinking*or*speech* •Trouble*remembering* Cataplexy*KK*suddenly*falling*asleep*or*losing*muscle*control*KK*which*is*part*of*narcolepsy,*is*NOT*a* symptom*of*idiopathic*hypersomnia.* Exams*and*Tests* The*health*care*provider*will*take*a*detailed*sleep*history.*Tests*may*include:* •MultipleKsleep*latency*test* •Sleep*study*(polysomnography,*to*identify*other*sleep*disorders)*
    [Show full text]
  • Insomnia-1111 30/11/11 4:37 PM Page 1
    SHF-Insomnia-1111 30/11/11 4:37 PM Page 1 Insomnia Important Things to Know About Insomnia • Around 1 in 3 people have at least mild insomnia. • Many poor sleepers have developed poor sleep habits. • For specialist help, cognitive behavioural therapy for insomnia is best • In the long run, taking sleeping pills isn’t effective. • There are sleep specialists, clinics and on-line programs that can help. What is insomnia? How common is insomnia? Insomnia is said to be present when you regularly find it Most people have experience insomnia symptoms at hard to fall asleep or stay asleep. It has several patterns. some time of their lives. At any given time around 10% You may have trouble getting to sleep initially. Or even if of people have at least mild insomnia. you can fall asleep, you might not be able to stay asleep for as long as you would like. Also you may wake up Who is at risk? during the night and not be able to go back to sleep for a long time. Many people have two of the above problems, Older people with poor health have a higher risk. Also or even all three. Because of these, you might feel tired women have twice the rates compared to men. This may during the day. be related to higher rates of anxiety and depression, which can be associated with insomnia. Shift workers What causes insomnia? have a higher risk too. Insomnia has many causes which can include: How does it affect people? • Some medicines and drugs, e.g.
    [Show full text]
  • Non-24-Hour Sleep-Wake Disorder Revisited – a Case Study
    CASE REPORT published: 29 February 2016 doi: 10.3389/fneur.2016.00017 Non-24-Hour Sleep-Wake Disorder Revisited – a Case study Corrado Garbazza1,2† , Vivien Bromundt3† , Anne Eckert2,4 , Daniel P. Brunner5 , Fides Meier2,4 , Sandra Hackethal6 and Christian Cajochen1,2* 1 Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, Switzerland, 2 Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Basel, Switzerland, 3 Sleep-Wake-Epilepsy-Centre, Department of Neurology, Inselspital, Bern University Hospital, Bern, Switzerland, 4 Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric Hospital of the University of Basel, Basel, Switzerland, 5 Center for Sleep Medicine, Hirslanden Clinic Zurich, Zurich, Switzerland, 6 Charité – Universitaetsmedizin Berlin, Berlin, Germany The human sleep-wake cycle is governed by two major factors: a homeostatic hourglass process (process S), which rises linearly during the day, and a circadian process C, which determines the timing of sleep in a ~24-h rhythm in accordance to the external Edited by: Ahmed S. BaHammam, light–dark (LD) cycle. While both individual processes are fairly well characterized, the King Saud University, Saudi Arabia exact nature of their interaction remains unclear. The circadian rhythm is generated by Reviewed by: the suprachiasmatic nucleus (“master clock”) of the anterior hypothalamus, through Axel Steiger, cell-autonomous feedback loops of DNA transcription and translation. While the phase Max Planck Institute of Psychiatry, Germany length (tau) of the cycle is relatively stable and genetically determined, the phase of Timo Partonen, the clock is reset by external stimuli (“zeitgebers”), the most important being the LD National Institute for Health and Welfare, Finland cycle.
    [Show full text]